NUBURU Inc. Announces Fourth Quarter and Full Year 2022 Financial Results
Fourth quarter and full year total revenue of
Launched Second Generation Product - NUBURU BL™-Series Lasers
“We ended 2022 on a high note as we began making deliveries under our previously announced contracts with Essentium and AFWERX. We have begun 2023 with the business momentum to pursue our near-term commercial and operational objectives as we completed our business combination and our listing on the NYSE American exchange and we continue to ship lasers systems,” said Dr.
Fourth Quarter and Full Year Financial Highlights (Unaudited)
Three Months Ended
|
$ Change |
% Change |
||||||||||||
($ in thousands) | 2022 |
|
2021 |
|
|
|
||||||||
Revenue | $ | 435 |
|
$ | 62 |
|
$ | 373 |
|
601.6 |
% |
|||
Total gross margin | (771 |
) |
(689 |
) |
(82 |
) |
11.9 |
% |
||||||
EBITDA⁽¹⁾ | (3,859 |
) |
(2,505 |
) |
(1,354 |
) |
54.1 |
% |
||||||
Capital expenditures | (254 |
) |
(110 |
) |
(144 |
) |
130.9 |
% |
||||||
Free cash flow⁽¹⁾ | (3,194 |
) |
(1,943 |
) |
(1,251 |
) |
64.4 |
% |
||||||
Year Ended
|
$ Change |
% Change |
||||||||||||
($ in thousands) | 2022 |
|
2021 |
|
||||||||||
Revenue | $ | 1,440 |
|
$ | 377 |
|
$ | 1,063 |
|
282.0 |
% |
|||
Total gross margin | (3,419 |
) |
(1,390 |
) |
(2,029 |
) |
146.0 |
% |
||||||
EBITDA⁽¹⁾ | (13,547 |
) |
(8,838 |
) |
(4,709 |
) |
53.3 |
% |
||||||
Capital expenditures | (536 |
) |
(426 |
) |
(110 |
) |
25.8 |
% |
||||||
Free cash flow⁽¹⁾ | (10,764 |
) |
(8,233 |
) |
(2,531 |
) |
30.7 |
% |
______________ | ||
(1) |
EBITDA and Free cash flow are non-GAAP financial measures. See “Use of Non-GAAP Financial Measures” below for our definitions of, and additional information about, EBITDA and Free cash flow and for a reconciliation to the most directly comparable |
“Our fourth quarter and full year 2022 results highlight the continuation of our commercialization efforts. Despite the difficult market conditions, we are pleased to have successfully completed our business combination, which we believe has positioned us well for continued growth in our target markets,” stated
Recent Business Highlights
- NUBURU completed its business combination resulting in NUBURU becoming a publicly listed company on the NYSE American exchange.
-
NUBURU announced the BL-Series Launch at Photonics West in
January 2023 . The BL-Series lasers are designed as easy-to-service packages that can readily integrate with scanners and beam delivery systems. - NUBURU has delivered multiple laser systems to Essentium for qualification into their metal additive manufacturing system.
-
NUBURU continues to deliver upon milestones per the previously announced contract with the
U.S. Air Force’s AFWERX. These milestones included delivery of multiple systems to the AFWERX sponsored additive program. - With the closing of the business combination, NUBURU expanded its board to include diverse and seasoned directors with the requisite public company experience to advise on NUBURU’s entrance to the public markets and the execution of its growth plans.
About NUBURU
Founded in 2015, NUBURU is a developer and manufacturer of industrial blue lasers that leverage fundamental physics and their high-brightness, high-power design to produce faster, higher quality welds and parts than current lasers can provide in laser welding and additive manufacturing of copper, gold, aluminum and other industrially important metals. NUBURU’s industrial blue lasers produce minimal to defect-free welds that are up to eight times faster than the traditional approaches — all with the flexibility inherent to laser processing.
Use of Non-GAAP Financial Measures
In this press release, the Company includes EBITDA and Free cash flow, which are non-GAAP performance measures that the Company uses to supplement its results presented in accordance with
EBITDA and Free Cash Flow
The Company defines “EBITDA” as income (loss), plus (minus) depreciation and amortization expenses, plus (minus) interest, plus (minus) taxes and “Free cash flow” as net cash from (used in) operating activities less capital expenditures. EBITDA and Free cash flow are intended as supplemental measures of the Company’s performance that are neither required by, nor presented in accordance with, GAAP and these measures should not be considered a substitute for net income (loss), and net cash used in operating activities reported in accordance with GAAP. The Company’s computation of EBITDA and Free cash flow may not be comparable to other similarly titled measures computed by other companies, because all companies may not calculate EBITDA or Free cash flow in the same fashion.
Limitations of Non-GAAP Financial Measures
There are a number of limitations related to EBITDA, including the following:
- EBITDA excludes certain recurring, non-cash charges, such as depreciation of property and equipment and/or amortization of intangible assets. While these are non-cash charges, the Company may need to replace the assets being depreciated and amortized in the future and EBITDA does not reflect cash requirements for these replacements or new capital expenditure requirements.
- EBITDA does not reflect interest expense, net, which may constitute a significant recurring expense in the future.
- Free cash flow does not reflect the impact of equity or debt raises or repayment of debt or dividends paid.
Because of these and other limitations, EBITDA and Free cash flow should not be considered in isolation or as a substitute for performance measures calculated in accordance with GAAP. The Company compensates for these limitations by relying primarily on the Company’s GAAP results and using EBITDA and Free cash flow on a supplemental basis. You should review the reconciliation of the Company’s net loss to EBITDA and net loss to Free cash flow below and not rely on any single financial measure to evaluate the Company’s business.
The Company’s presentation of EBITDA should not be construed as an inference that its future results will be unaffected by unusual or non-recurring items and its presentation of Free cash flow does not necessarily indicate whether cash flows will be sufficient to fund its cash needs.
Forward-Looking Statements
This press release contains certain “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including certain financial forecasts and projections. All statements other than statements of historical fact contained in this press release may be forward-looking statements. Some of these forward-looking statements can be identified by the use of forward-looking words, including “may,” “should,” “expect,” “intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,” “plan,” “seek,” “targets,” “projects,” “could,” “would,” “continue,” “forecast” or the negatives of these terms or variations of them or similar expressions. All forward-looking statements are subject to risks, uncertainties, and other factors which could cause actual results to differ materially from those expressed or implied by such forward-looking statements. All forward-looking statements are based upon estimates, forecasts and assumptions that, while considered reasonable by NUBURU and its management, are inherently uncertain and many factors may cause the Company’s actual results to differ materially from current expectations which include, but are not limited to: (1) the ability to continue to meet the security exchange’s listing standards; (2) failure to achieve expectations regarding its product development and pipeline; (3) the inability to access sufficient capital to operate as anticipated; (4) the risk that the business combination disrupts current plans and operations of NUBURU as a result of the consummation of the business combination; (5) the inability to recognize the anticipated benefits of the business combination, which may be affected by, among other things, competition, the ability of the Company to grow and manage growth profitably, maintain relationships with customers and suppliers and retain its management and key employees; (6) changes in applicable laws or regulations; (7) the possibility that NUBURU may be adversely affected by other economic, business and/or competitive factors; (8) the inability to obtain financing from
|
||||||
|
|
|||||
|
|
2022 |
|
|
2021 |
|
ASSETS |
||||||
Current assets: |
|
|
||||
Cash and cash equivalents |
$ |
2,880,254 |
|
$ |
6,007,575 |
|
Accounts receivable |
|
327,200 |
|
|
223,275 |
|
Inventories, net |
|
972,695 |
|
|
410,098 |
|
Deferred financing costs |
|
4,258,515 |
|
|
- |
|
Prepaid expenses and other |
|
46,737 |
|
|
70,073 |
|
Total current assets |
|
8,485,401 |
|
|
6,711,021 |
|
|
|
|
||||
Property and equipment, net |
|
3,771,849 |
|
|
3,980,280 |
|
Construction in progress |
|
188,912 |
|
|
- |
|
Right-of-use assets |
|
641,651 |
|
|
- |
|
Deposits |
|
34,359 |
|
|
34,359 |
|
TOTAL ASSETS |
$ |
13,122,172 |
|
$ |
10,725,660 |
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY |
||||||
Current liabilities: |
|
|
||||
Accounts payable |
$ |
4,456,587 |
|
$ |
221,188 |
|
Accrued expenses |
|
2,312,118 |
|
|
646,863 |
|
Operating lease liability |
|
343,049 |
|
|
- |
|
Contract liabilities |
|
178,750 |
|
|
173,050 |
|
Convertible notes payable |
|
7,300,000 |
|
|
- |
|
Total current liabilities |
|
14,590,504 |
|
|
1,041,101 |
|
|
|
|
||||
Deferred rent |
|
- |
|
|
96,484 |
|
Operating lease liability, net of current portion |
|
373,907 |
|
|
- |
|
Total liabilities |
|
14,964,411 |
|
|
1,137,585 |
|
|
|
|
||||
Stockholders' (deficit) equity: |
|
|
||||
Preferred stock |
|
|
||||
Series A preferred stock, |
|
800 |
|
|
800 |
|
Series A‑1 preferred stock, |
|
348 |
|
|
348 |
|
Series B preferred stock, |
|
312 |
|
|
312 |
|
Series B‑1 preferred stock, |
|
2,463 |
|
|
2,463 |
|
Series C preferred stock, |
|
117 |
|
|
113 |
|
Common stock, |
|
1,077 |
|
|
999 |
|
Additional paid‑in capital |
|
59,344,952 |
|
|
56,646,247 |
|
Accumulated deficit |
|
(61,192,308 |
) |
|
(47,063,207 |
) |
Total stockholders' (deficit) equity |
|
(1,842,239 |
) |
|
9,588,075 |
|
|
|
|
||||
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY |
$ |
13,122,172 |
|
$ |
10,725,660 |
|
|
|
|
|
||||||
|
Year Ended |
|||||
|
|
2022 |
|
|
2021 |
|
|
|
|
||||
Net revenues |
$ |
1,440,428 |
|
$ |
376,665 |
|
|
|
|
||||
Cost of revenues |
|
|
||||
Materials |
|
472,440 |
|
|
24,605 |
|
Direct labor |
|
1,742,796 |
|
|
570,432 |
|
Direct job costs |
|
2,391,796 |
|
|
822,509 |
|
Overhead |
|
252,567 |
|
|
348,723 |
|
|
|
|
||||
Total cost of revenues |
|
4,859,599 |
|
|
1,766,269 |
|
|
|
|
||||
Gross deficit |
|
(3,419,171 |
) |
|
(1,389,604 |
) |
|
|
|
||||
Operating expenses |
|
|
||||
Research and development |
|
4,546,057 |
|
|
2,463,307 |
|
Sales and marketing |
|
708,144 |
|
|
1,647,552 |
|
General and administrative |
|
5,324,417 |
|
|
3,884,677 |
|
|
|
|
||||
Total operating expenses |
|
10,578,618 |
|
|
7,995,536 |
|
|
|
|
||||
Loss from operations |
|
(13,997,789 |
) |
|
(9,385,140 |
) |
|
|
|
||||
Other income (expense) |
|
|
||||
Interest income |
|
43,976 |
|
|
1,165 |
|
Interest expense |
|
(175,288 |
) |
|
- |
|
|
|
|
||||
Total other income (expense) |
|
(131,312 |
) |
|
1,165 |
|
|
|
|
||||
Net loss and comprehensive loss |
$ |
(14,129,101 |
) |
$ |
(9,383,975 |
) |
|
|
|
||||
Net loss available to common stockholders |
$ |
(17,317,546 |
) |
$ |
(12,240,023 |
) |
|
|
|
||||
Net loss per common share – basic and diluted |
$ |
(1.64 |
) |
$ |
(1.23 |
) |
|
|
|
||||
Weighted average common shares outstanding – basic and diluted |
|
10,590,335 |
|
|
9,973,846 |
|
|
||||||
|
Year Ended |
|||||
|
|
2022 |
|
|
2021 |
|
|
|
|
||||
Cash flows from operating activities |
|
|
||||
Net loss |
$ |
(14,129,101 |
) |
$ |
(9,383,975 |
) |
Adjustments to reconcile net loss to cash used in operating activities: |
|
|
||||
Depreciation and amortization |
|
450,505 |
|
|
546,944 |
|
Share based compensation expense |
|
2,362,340 |
|
|
441,367 |
|
Loss on disposal of property and equipment |
|
- |
|
|
147,469 |
|
Excess and obsolete inventory reserve adjustments |
|
(590,137 |
) |
|
236,748 |
|
Inventory lower of cost and net realizable value adjustments |
|
332,021 |
|
|
329,331 |
|
Changes in operating assets and liabilities: |
|
|
||||
Inventories |
|
(199,429 |
) |
|
(234,503 |
) |
Accounts Receivable |
|
(103,925 |
) |
|
(170,275 |
) |
Prepaid expenses and other |
|
23,336 |
|
|
(45,813 |
) |
Operating lease right-of-use asset |
|
292,932 |
|
|
- |
|
Accounts payable |
|
628,702 |
|
|
(24,147 |
) |
Accrued expenses |
|
1,013,437 |
|
|
223,631 |
|
Contract liabilities |
|
5,700 |
|
|
137,274 |
|
Operating lease liability |
|
(314,111 |
) |
|
- |
|
Deferred rent |
|
- |
|
|
(10,846 |
) |
|
|
|
||||
Net cash used in operating activities |
|
(10,227,730 |
) |
|
(7,806,795 |
) |
|
|
|
||||
Cash flows from investing activities |
|
|
||||
Proceeds from the sale of property and equipment |
|
- |
|
|
195,492 |
|
Purchases of property and equipment |
|
(536,038 |
) |
|
(426,445 |
) |
|
|
|
||||
Net cash used in investing activities |
|
(536,038 |
) |
|
(230,953 |
) |
|
|
|
||||
Cash flows from financing activities |
|
|
||||
Proceeds from issuance of convertible promissory note |
|
7,300,000 |
|
|
- |
|
Proceeds from issuance of common stock ‑ options exercised |
|
147,557 |
|
|
7,800 |
|
Proceeds from issuance of preferred stock |
|
188,890 |
|
|
5,642,970 |
|
|
|
|
||||
Net cash provided by financing activities |
|
7,636,447 |
|
|
5,650,770 |
|
|
|
|
||||
Net decrease in cash and cash equivalents |
|
(3,127,321 |
) |
|
(2,386,978 |
) |
|
|
|
||||
Cash and cash equivalents, beginning of period |
|
6,007,575 |
|
|
8,394,553 |
|
|
|
|
||||
Cash and cash equivalents, end of period |
$ |
2,880,254 |
|
$ |
6,007,575 |
|
|
|
|
||||
Supplemental non-cash flow investing and financing activities: |
|
|
||||
Right-of-use asset obtained in exchange for new operating lease liability |
$ |
934,583 |
|
$ |
- |
|
Deferred financing costs included in accounts payable and accrued expenses |
$ |
4,258,515 |
|
$ |
- |
|
|
|
|
Reconciliation of Non-GAAP Financial Measures:
The following tables reconcile the Company’s net loss (the most directly comparable GAAP measure to EBITDA) to EBITDA for the periods presented and the Company’s net cash used in operating activities (the most directly comparable GAAP measure to Free Cash Flow) to Free cash flow for the periods presented:
Three Months Ended |
|||||||||
($ in thousands) |
|
2022 |
|
|
2021 |
|
|||
Net loss | $ |
(4,022 |
) |
$ |
(2,644 |
) |
|||
Income tax expense |
|
- |
|
|
- |
|
|||
Interest (Income) expense, net |
|
93 |
|
|
- |
|
|||
Depreciation and amortization |
|
70 |
|
|
139 |
|
|||
EBITDA |
|
(3,859 |
) |
|
(2,505 |
) |
|||
Three Months Ended |
|||||||||
($ in thousands) |
|
2022 |
|
|
2021 |
|
|||
Net cash used in operating activities | $ |
(2,940 |
) |
$ |
(1,833 |
) |
|||
Capital expenditures |
|
(254 |
) |
|
(110 |
) |
|||
Free cash flow |
|
(3,194 |
) |
|
(1,943 |
) |
Year Ended |
|||||||||
($ in thousands) |
|
2022 |
|
|
2021 |
|
|||
Net loss | $ |
(14,129 |
) |
$ |
(9,384 |
) |
|||
Income tax expense |
|
- |
|
|
- |
|
|||
Interest (Income) expense, net |
|
131 |
|
|
(1 |
) |
|||
Depreciation and amortization |
|
451 |
|
|
547 |
|
|||
EBITDA |
|
(13,547 |
) |
|
(8,838 |
) |
|||
Year Ended |
|||||||||
($ in thousands) |
|
2022 |
|
|
2021 |
|
|||
Net cash used in operating activities | $ |
(10,228 |
) |
$ |
(7,807 |
) |
|||
Capital expenditures |
|
(536 |
) |
|
(426 |
) |
|||
Free cash flow |
|
(10,764 |
) |
|
(8,233 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230221005548/en/
NUBURU - Media Contact
ir@nuburu.net
NUBURU - Investor Relations Contact
Maria@blueshirtgroup.com
Source: